https://www.healthwellnesstodaynewyork.com/article/903522766-uog-united-one-america-inc-positions-wearable-wellness-as-a-new-category-following-ces-2026-recognition Health & Wellness Today New York en PressRelease 2026-04-03T18:15:00+00:00 UOG (United One) America, Inc Positions Wearable Wellness as a New Category Following CES 2026 Recognition https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24565344-ces-2026-awards-uog-wellness-1200x628.png https://www.healthwellnesstodaynewyork.com/article/903542991-flashes-of-grief-flashes-of-hope-is-a-deeply-personal-and-emotionally-resonant-memoir Health & Wellness Today New York en PressRelease 2026-04-03T12:48:08+00:00 Flashes of Grief, Flashes of Hope Is a Deeply Personal and Emotionally Resonant Memoir https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24825624-flashes-of-grief-flashes-of-ho-334x500.jpeg https://www.healthwellnesstodaynewyork.com/article/903620755-anika-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-03T21:00:00+00:00 Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/342e50d9-f0e4-4e79-b568-840299c2045d/small/anika-new-logo-blue-1200x628-png.png https://www.healthwellnesstodaynewyork.com/article/903620870-matinas-biopharma-receives-notice-of-non-compliance-with-nyse-american-continued-listing-standards Health & Wellness Today New York en PressRelease 2026-04-03T21:00:00+00:00 Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards https://ml.globenewswire.com/media/3e39a977-df68-4f07-8991-d85b43720347/small/matinas-biopharma.jpg https://www.healthwellnesstodaynewyork.com/article/903620710-oric-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-03T20:30:00+00:00 ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/acbc0ad2-7a44-4ee7-b729-ab92d57ffafb/small/oric-png.png https://www.healthwellnesstodaynewyork.com/article/903620924-xilio-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-03T20:30:00+00:00 Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/7e55cc25-f46f-423c-bf2a-e77ebaf69665/small/xilio-full-clr-logo-cmyk-png.png https://www.healthwellnesstodaynewyork.com/article/903621062-aeon-biopharma-reports-inducement-grants-under-nyse-american-llc-company-guide-section-711 Health & Wellness Today New York en PressRelease 2026-04-03T20:10:00+00:00 AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 https://ml.globenewswire.com/media/c49be6f2-5e65-4a6d-9aef-e6b695554fb6/small/aeon-logo-png.png https://www.healthwellnesstodaynewyork.com/article/903620976-intellia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-03T20:05:00+00:00 Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903621070-aeon-biopharma-receives-additional-notice-related-to-nyse-american-continued-listing-standards Health & Wellness Today New York en PressRelease 2026-04-03T20:05:00+00:00 AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards https://ml.globenewswire.com/media/c49be6f2-5e65-4a6d-9aef-e6b695554fb6/small/aeon-logo-png.png https://www.healthwellnesstodaynewyork.com/article/903620719-syndax-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-03T20:01:00+00:00 Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/399a65b5-bd4f-4ba5-980b-f4d0af9ae6a0/small/syndax-logo-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903620728-spyre-therapeutics-announces-grants-of-inducement-awards Health & Wellness Today New York en PressRelease 2026-04-03T20:01:00+00:00 Spyre Therapeutics Announces Grants of Inducement Awards https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903620674-in8bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-03T20:00:00+00:00 IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/ab4056e8-16d0-4c44-9ee8-367a47f6ef78/small/in8biologo-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903605154-vitalrize-claims-evaluated-the-max-vitalize-virility-enhancement-support-supplement-for-men Health & Wellness Today New York en PressRelease 2026-04-03T19:56:10+00:00 VitalRIZE Claims Evaluated: The Max Vitalize Virility Enhancement Support Supplement for Men https://zingfast.com/wp-content/uploads/2026/04/VitalRIZE.jpg https://www.healthwellnesstodaynewyork.com/article/903605152-power-life-high-impact-plant-protein-claims-evaluated-the-cleanest-vegan-protein-powder-on-the-market-by-powerlife Health & Wellness Today New York en PressRelease 2026-04-03T19:52:09+00:00 Power Life High Impact Plant Protein Claims Evaluated: The Cleanest Vegan Protein Powder on the Market by PowerLife https://zingfast.com/wp-content/uploads/2026/04/Power-Life-High-Impact-Plant-Protein.jpg https://www.healthwellnesstodaynewyork.com/article/903604955-weight-watchers-announces-leadership-transition-and-board-updates Health & Wellness Today New York en PressRelease 2026-04-03T18:09:00+00:00 Weight Watchers Announces Leadership Transition and Board Updates  https://ml.globenewswire.com/media/f435b439-7f75-4d2f-a6cc-0e4e2ed811ea/small/weightwatchers-wordmark-boldblue-png.png https://www.healthwellnesstodaynewyork.com/article/903604807-inhibikase-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-03T18:01:00+00:00 Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/32b8d8bc-ebf8-43c0-866a-6613b22263b1/small/ikt-logo-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903588548-impact-biomedical-inc-reports-going-concern-audit-opinion-in-2025-10-k-filing-while-continuing-strategic-merger-plans Health & Wellness Today New York en PressRelease 2026-04-03T17:52:41+00:00 Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans https://ml.globenewswire.com/media/5eb787ba-e418-4ec9-ab20-690ee7931414/small/impact-biomedical-inc-logo-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903587863-maximus-ranked-7-on-the-financial-times-list-of-the-americas-fastest-growing-companies-2026 Health & Wellness Today New York en PressRelease 2026-04-03T17:40:00+00:00 Maximus Ranked #7 on the Financial Times’ List of The Americas’ Fastest Growing Companies 2026 https://ml.globenewswire.com/media/14a794f6-c8ea-4fbc-9beb-e62c30608977/small/screenshot-2025-08-12-at-3-14-43-pm-png.png https://www.healthwellnesstodaynewyork.com/article/903588161-denali-therapeutics-regains-full-rights-to-investigational-therapy-dnl593-ptv-pgrn-for-grn-related-frontotemporal-dementia-ftd-grn Health & Wellness Today New York en PressRelease 2026-04-03T17:30:00+00:00 Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN) https://ml.globenewswire.com/media/898f19a9-f6ef-4d5a-8a4f-27709b81609a/small/denali-green-logo-png.png https://www.healthwellnesstodaynewyork.com/article/903574137-global-virus-network-monitors-sars-cov-2-variant-ba-3-2-cicada-emphasizes-no-cause-for-alarm Health & Wellness Today New York en PressRelease 2026-04-03T16:00:39+00:00 Global Virus Network Monitors SARS-CoV-2 Variant BA.3.2 (“Cicada”), Emphasizes No Cause for Alarm https://ml.globenewswire.com/media/6c1b2724-7b9b-469a-a7c3-bc0a64d716ae/small/gvn-lt-gr-gradiant-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903571682-air-diet-review-the-air-fryer-meal-plan-for-personalized-nutrition Health & Wellness Today New York en PressRelease 2026-04-03T14:32:35+00:00 Air Diet Review: The Air-Fryer Meal Plan For Personalized Nutrition https://ml-eu.globenewswire.com/media/2b5daf87-d3b4-42d4-86d2-92aea2a2d23c/medium/lose-weight-with-personalized-air-fryer-diet.png https://www.healthwellnesstodaynewyork.com/article/903555236-rhythm-pharmaceuticals-announces-changes-to-board-of-directors Health & Wellness Today New York en PressRelease 2026-04-03T13:00:00+00:00 Rhythm Pharmaceuticals Announces Changes to Board of Directors https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903554922-bicara-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-03T12:30:00+00:00 Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/fdf5e06f-0748-428a-8f90-b0a1c6f7bdf3/small/bicara-logo-struck-png.png https://www.healthwellnesstodaynewyork.com/article/903554873-mbx-biosciences-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-03T12:00:00+00:00 MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/5499b327-bce0-4a3f-96a7-04a38b68a99f/small/mbx-logos-final-full-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903555000-taysha-gene-therapies-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-03T12:00:00+00:00 Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/a88cd5f5-0b05-416c-a56b-e4130c10cfca/small/new-taysha-inline-fullcolor-rgb-12in-300ppi-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903535955-mink-therapeutics-and-memorial-sloan-kettering-to-present-phase-ii-study-of-agent-797-combination-in-pd-1-refractory-gastroesophageal-cancer-at-aacr Health & Wellness Today New York en PressRelease 2026-04-03T11:30:00+00:00 MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026 https://ml.globenewswire.com/media/6aa8e960-515a-40d6-9894-39ca47f5c84e/small/mink-logo-loyal-blue-and-light-blue-png.png https://www.healthwellnesstodaynewyork.com/article/903535988-kura-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-03T11:30:00+00:00 Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://www.healthwellnesstodaynewyork.com/article/903535857-biocryst-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-03T11:00:00+00:00 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/8b033909-1a3c-4811-b07b-fe03b12e00d2/small/biocryst-primarylogo-r-2c-rgb-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903154961-emmi-technologies-joins-the-north-carolina-healthcare-association-as-approved-business-partner Health & Wellness Today New York en PressRelease 2026-04-02T16:00:00+00:00 EMMI Technologies Joins the North Carolina Healthcare Association as Approved Business Partner https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24823537-emmitec-health-logo-1840x257.jpeg https://www.healthwellnesstodaynewyork.com/article/903356408-steven-batash-m-d-has-been-awarded-a-2025-ny-top-doc Health & Wellness Today New York en PressRelease 2026-04-02T15:04:33+00:00 Steven Batash, M.D. Has Been Awarded A 2025 NY Top Doc https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24824865-dr-steven-batash-940x788.png https://www.healthwellnesstodaynewyork.com/article/903001162-black-talon-security-ceo-gary-salman-highlights-essential-cyber-strategy-at-vive-digital-healthcare-conference Health & Wellness Today New York en PressRelease 2026-04-02T12:30:00+00:00 Black Talon Security CEO Gary Salman Highlights Essential Cyber Strategy At ViVE Digital Healthcare Conference https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24822773-vive-2026-gary-salman-and-and-1620x962.png https://www.healthwellnesstodaynewyork.com/article/903438283-cacao-bliss-claims-evaluated-the-natural-glp-1-superfood-alternative-earth-echo-s-chocolate-drink-mix-for-weight-loss Health & Wellness Today New York en PressRelease 2026-04-03T00:10:00+00:00 Cacao Bliss Claims Evaluated: The Natural GLP-1 Superfood Alternative, Earth Echo's Chocolate Drink Mix for Weight Loss https://zingfast.com/wp-content/uploads/2026/04/Cacao-Bliss.jpg https://www.healthwellnesstodaynewyork.com/article/903419453-mesa-labs-declares-quarterly-dividend Health & Wellness Today New York en PressRelease 2026-04-02T22:00:00+00:00 MESA LABS DECLARES QUARTERLY DIVIDEND https://ml.globenewswire.com/media/ff66b401-9246-47b9-accc-2f553d346c5c/small/mesalogo-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903419573-merit-medical-systems-to-announce-first-quarter-2026-results-on-april-30-2026 Health & Wellness Today New York en PressRelease 2026-04-02T22:00:00+00:00 Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026 https://ml.globenewswire.com/media/19958d8f-47a4-44f3-a780-247335a68768/small/merit-medical-systems-inc-logo.jpg https://www.healthwellnesstodaynewyork.com/article/903419504-conavi-medical-announces-results-from-its-annual-general-meeting-of-shareholders Health & Wellness Today New York en PressRelease 2026-04-02T21:44:30+00:00 Conavi Medical Announces Results from Its Annual General Meeting of Shareholders https://ml.globenewswire.com/media/4a28f1c0-f99d-4940-b2a7-201ab98cdaff/small/conavi-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903419498-newamsterdam-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-02T21:43:42+00:00 NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/f7b8b881-9461-4712-9965-707ed3bdd573/small/newamsterdam-logo-full-color-final-png.png https://www.healthwellnesstodaynewyork.com/article/903418492-information-regarding-the-total-number-of-voting-rights-and-total-number-of-shares-of-the-company-as-of-march-31-2026 Health & Wellness Today New York en PressRelease 2026-04-02T20:30:00+00:00 Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 https://ml-eu.globenewswire.com/media/274bd0ae-19c4-4821-85ce-7fe85ee610b5/small/logo1-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903418496-information-relative-au-nombre-total-des-droits-de-vote-et-d-actions-composant-le-capital-social-au-31-mars-2026 Health & Wellness Today New York en PressRelease 2026-04-02T20:30:00+00:00 Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mars 2026 https://ml-eu.globenewswire.com/media/274bd0ae-19c4-4821-85ce-7fe85ee610b5/small/ https://www.healthwellnesstodaynewyork.com/article/903418721-olema-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-02T20:30:00+00:00 Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/9c736753-c905-4bd1-ac3a-1444bea84331/small/olema-logo-rgb-png.png https://www.healthwellnesstodaynewyork.com/article/903418919-regeneron-collaborates-with-trinetx-to-access-de-identified-electronic-health-records-of-300-million-patients-to-drive-research-and-product Health & Wellness Today New York en PressRelease 2026-04-02T20:30:00+00:00 Regeneron Collaborates with TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903419450-serina-therapeutics-announces-nyse-american-acceptance-of-continued-listing-compliance-plan Health & Wellness Today New York en PressRelease 2026-04-02T20:13:00+00:00 Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan https://ml.globenewswire.com/media/7f8e4304-8465-4d4d-a7e3-ebc4eae51f29/small/yellow-burts-blue-text-1-png.png https://www.healthwellnesstodaynewyork.com/article/903418718-rxsight-inc-to-participate-in-the-25th-annual-needham-virtual-healthcare-conference Health & Wellness Today New York en PressRelease 2026-04-02T20:10:00+00:00 RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference https://ml.globenewswire.com/media/48441335-c938-45ff-9355-ba8e331354e9/small/rxsight-globe-png.png https://www.healthwellnesstodaynewyork.com/article/903418651-equillium-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-02T20:05:00+00:00 Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/14ce766d-e697-461f-a27c-c1ee49c0eeff/small/equillium-logo-360x180-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903418710-terns-pharmaceuticals-reports-inducement-grants-to-new-employees-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-02T20:05:00+00:00 Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) https://ml.globenewswire.com/media/cfd0bb0d-8a9b-4de4-92ce-47e8018cf3d9/small/terns-logo-rgbs-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903418769-relay-therapeutics-to-present-initial-clinical-data-on-zovegalisib-in-vascular-anomalies-at-the-international-society-for-the-study-of-vascular Health & Wellness Today New York en PressRelease 2026-04-02T20:05:00+00:00 Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026 https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png https://www.healthwellnesstodaynewyork.com/article/903418814-fate-therapeutics-reports-new-employee-inducement-award-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-02T20:05:00+00:00 Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903418840-candel-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-02T20:05:00+00:00 Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png https://www.healthwellnesstodaynewyork.com/article/903418845-minerva-announces-leadership-transition Health & Wellness Today New York en PressRelease 2026-04-02T20:05:00+00:00 Minerva Announces Leadership Transition https://ml.globenewswire.com/media/69e604cb-25b6-4235-ae9a-17c25cc158b9/small/minerva-logo.jpg https://www.healthwellnesstodaynewyork.com/article/903419076-akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-02T20:05:00+00:00 Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/c7f3708e-3328-4668-95c6-e7646efd653a/small/akebia-logo-fullcolor-rgb-png.png https://www.healthwellnesstodaynewyork.com/article/903398555-fibrobiologics-announces-closing-of-3-million-public-offering Health & Wellness Today New York en PressRelease 2026-04-02T20:01:00+00:00 FibroBiologics Announces Closing of $3 Million Public Offering https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903399500-praxis-precision-medicines-inc-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-02T20:01:00+00:00 Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903400112-summary-notice-of-pendency-and-proposed-settlement-of-stockholder-derivative-actions Health & Wellness Today New York en PressRelease 2026-04-02T20:01:00+00:00 Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions https://ml.globenewswire.com/media/3a5f958d-422c-4a97-a96d-cf06f640b587/small/exicure-logo-final-full-color-072515-png.png https://www.healthwellnesstodaynewyork.com/article/903400085-visory-health-se-posiciona-entre-las-principales-tarjetas-de-descuento-para-medicamentos-bajo-prescripci-n-en-estados-unidos-ofreciendo-a-millones-de Health & Wellness Today New York en PressRelease 2026-04-02T19:40:55+00:00 Visory Health se posiciona entre las principales tarjetas de descuento para medicamentos bajo prescripción en Estados Unidos, ofreciendo a millones de personas acceso a tratamientos asequibles https://ml.globenewswire.com/media/e5a74903-3e24-4101-9d07-c377482b32ec/small/visory-health-logo-png.png https://www.healthwellnesstodaynewyork.com/article/903400069-get-summer-season-ready-with-new-notorious-fitness-training-plans Health & Wellness Today New York en PressRelease 2026-04-02T19:35:59+00:00 Get Summer-Season Ready with New Notorious Fitness Training Plans https://ml.globenewswire.com/media/485cb087-ce87-45bc-bd40-7b164d7bda7a/small/logo-ni-png.png https://www.healthwellnesstodaynewyork.com/article/903400049-mediwound-reports-barda-contract-award-to-vericel-for-nexobrid-valued-at-up-to-197-million Health & Wellness Today New York en PressRelease 2026-04-02T19:26:11+00:00 MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million https://ml.globenewswire.com/media/55509183-b8b9-4da4-ae63-92c83760b5d9/small/mdwd-logo-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903399638-vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid Health & Wellness Today New York en PressRelease 2026-04-02T18:40:00+00:00 Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid https://ml.globenewswire.com/media/6a144258-8523-493f-8a1e-ccceec233208/small/vericel-corporation-logo.jpg https://www.healthwellnesstodaynewyork.com/article/903382944-cherry-picking-science-wva-condemns-eu-tobacco-report Health & Wellness Today New York en PressRelease 2026-04-02T16:39:14+00:00 Cherry-Picking Science: WVA Condemns EU Tobacco Report https://ml.globenewswire.com/media/23d44cef-b934-4430-a66e-f7a36a326666/medium/world-vapers-alliance.jpeg https://www.healthwellnesstodaynewyork.com/article/903380596-genfit-r-sultats-financiers-annuels-2025-et-point-sur-les-activit-s-de-la-soci-t Health & Wellness Today New York en PressRelease 2026-04-02T16:30:20+00:00 GENFIT : Résultats financiers annuels 2025 et point sur les activités de la Société   https://ml-eu.globenewswire.com/media/ZTkzMGRhNzItOGJkZS00NWRhLTllNWYtY2RmZmVhMWVlNTZiLTEwMTEyNjgtMjAyNi0wNC0wMi1mcg==/tiny/GENFIT-S-A-.png https://www.healthwellnesstodaynewyork.com/article/903380643-genfit-reports-full-year-2025-financial-results-and-provides-corporate-update Health & Wellness Today New York en PressRelease 2026-04-02T16:30:20+00:00 GENFIT Reports Full-Year 2025 Financial Results and Provides Corporate Update   https://ml-eu.globenewswire.com/media/ZTkzMGRhNzItOGJkZS00NWRhLTllNWYtY2RmZmVhMWVlNTZiLTEwMTEyNjgtMjAyNi0wNC0wMi1lbg==/tiny/GENFIT-S-A-.png https://www.healthwellnesstodaynewyork.com/article/903380423-medicana-health-group-marks-world-autism-awareness-day-with-a-call-for-inclusion-earlier-recognition-and-family-centered-support Health & Wellness Today New York en PressRelease 2026-04-02T16:00:00+00:00 Medicana Health Group Marks World Autism Awareness Day with a Call for Inclusion, Earlier Recognition and Family-Centered Support  https://ml-eu.globenewswire.com/media/4552042c-da21-40b5-90e7-122b99c64bff/medium/medicana-atakoy-hospital.png https://www.healthwellnesstodaynewyork.com/article/903381718-eylea-hd-aflibercept-approved-by-fda-as-first-and-only-injectable-anti-vegf-with-dosing-intervals-up-to-5-months-for-wet-age-related-macular Health & Wellness Today New York en PressRelease 2026-04-02T16:00:00+00:00 EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME) https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903360628-liv-hospital-highlights-hospital-based-stem-cell-infrastructure-during-autism-awareness-month Health & Wellness Today New York en PressRelease 2026-04-02T15:00:00+00:00 Liv Hospital Highlights Hospital-Based Stem Cell Infrastructure During Autism Awareness Month https://ml-eu.globenewswire.com/media/56455831-7774-4cd6-b91c-6ed239d89950/medium/liv-hospital-highlights-hospital-based-stem-cell-infrastruct.jpg https://www.healthwellnesstodaynewyork.com/article/903363207-global-virus-network-meeting-advances-a-science-driven-agenda-for-pandemic-preparedness Health & Wellness Today New York en PressRelease 2026-04-02T15:00:00+00:00 Global Virus Network Meeting Advances a Science-Driven Agenda for Pandemic Preparedness https://ml.globenewswire.com/media/6c1b2724-7b9b-469a-a7c3-bc0a64d716ae/small/gvn-lt-gr-gradiant-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903364235-abbvie-ibd-scholarship-program-marks-15-years-applications-open-for-2026 Health & Wellness Today New York en PressRelease 2026-04-02T15:00:00+00:00 AbbVie IBD Scholarship Program Marks 15 Years: Applications Open for 2026 https://ml.globenewswire.com/media/d853f38f-4056-484f-94ad-0d49eccd29ee/small/ccc-logo-pr-png.png https://www.healthwellnesstodaynewyork.com/article/903364241-le-programme-de-bourses-d-tudes-mii-d-abbvie-f-te-ses-15-ans-les-candidatures-sont-ouvertes-pour-2026 Health & Wellness Today New York en PressRelease 2026-04-02T15:00:00+00:00 Le programme de bourses d'études MII d’AbbVie fête ses 15 ans : les candidatures sont ouvertes pour 2026 https://ml.globenewswire.com/media/d853f38f-4056-484f-94ad-0d49eccd29ee/small/ https://www.healthwellnesstodaynewyork.com/article/903360645-assisted-reproductive-technology-market-set-to-reach-6-02-billion-by-2030-marketsandmarkets Health & Wellness Today New York en PressRelease 2026-04-02T14:30:00+00:00 Assisted Reproductive Technology Market Set to Reach $6.02 Billion by 2030 | MarketsandMarkets™ https://ml.globenewswire.com/media/afcc5182-4ae0-43a8-a965-4351d590b7ed/small/mnm-logo-tm-jpg-jpg.JPG https://www.healthwellnesstodaynewyork.com/article/903363417-paul-markovich-discusses-healthcare-reform-through-the-worthy-movement-on-yourupdatetv Health & Wellness Today New York en PressRelease 2026-04-02T14:12:48+00:00 Paul Markovich Discusses Healthcare Reform Through the Worthy Movement on YourUpdateTV https://ml.globenewswire.com/media/5115f449-412d-4a05-bbcb-add09b3f2838/small/blank-logo-png.png https://www.healthwellnesstodaynewyork.com/article/903362971-biocardia-files-request-for-meeting-with-fda-to-discuss-accelerated-approval-pathway-for-cardiamp-system-in-ischemic-heart-failure Health & Wellness Today New York en PressRelease 2026-04-02T14:11:34+00:00 BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure https://ml.globenewswire.com/media/4641bb53-4913-4654-a337-79383a5c7ab9/small/biocardia-final-logo-2016-jpeg-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903362873-visory-health-ranks-among-top-u-s-prescription-cards-providing-millions-of-americans-access-to-affordable-medications Health & Wellness Today New York en PressRelease 2026-04-02T14:11:09+00:00 Visory Health Ranks Among Top U.S. Prescription Cards Providing Millions of Americans Access to Affordable Medications https://ml.globenewswire.com/media/e5a74903-3e24-4101-9d07-c377482b32ec/small/visory-health-logo-png.png https://www.healthwellnesstodaynewyork.com/article/903362348-curonix-llc-announces-expanded-reimbursement-coverage-for-freedom-peripheral-nerve-stimulator-pns-system-providing-access-to-an-additional-27 Health & Wellness Today New York en PressRelease 2026-04-02T14:00:00+00:00 Curonix LLC Announces Expanded Reimbursement Coverage for Freedom® Peripheral Nerve Stimulator (PNS) System, Providing Access To An Additional 27 Million Covered Lives Nationwide https://ml.globenewswire.com/media/6eea76ae-3d4d-421b-886f-9e9da10f08bf/small/curonix-primarylogo-cmyk-png.png https://www.healthwellnesstodaynewyork.com/article/903362591-geneproof-announces-cmv-ivdr-launch-on-the-mycrobe-fully-automated-system-for-transplant-care Health & Wellness Today New York en PressRelease 2026-04-02T13:59:06+00:00 GeneProof Announces CMV IVDR Launch on the myCROBE™ Fully Automated System for Transplant Care https://ml.globenewswire.com/media/MDJlNGYyYTgtNjZhNC00MmIxLTgwYmQtNzVjMDg5MDk1MTM3LTUwMDE2MDU3Mi0yMDI2LTA0LTAyLWVu/tiny/GeneProof-part-of-NuvinkaDX.png https://www.healthwellnesstodaynewyork.com/article/903362218-mimedx-to-sponsor-leading-advanced-wound-care-conferences Health & Wellness Today New York en PressRelease 2026-04-02T13:15:00+00:00 MIMEDX to Sponsor Leading Advanced Wound Care Conferences https://ml.globenewswire.com/media/2a60ab36-4917-479c-b53a-4f2113ca347d/small/mimedx-png.png https://www.healthwellnesstodaynewyork.com/article/903344419-global-flexible-pcb-market-to-nearly-double-reaching-41-7-billion-by-2030-on-surging-demand-from-consumer-electronics-evs-and-5g-infrastructure Health & Wellness Today New York en PressRelease 2026-04-02T13:06:30+00:00 Global Flexible PCB Market to Nearly Double, Reaching $41.7 Billion by 2030 on Surging Demand from Consumer Electronics, EVs and 5G Infrastructure https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.healthwellnesstodaynewyork.com/article/903343209-from-lab-fiber-to-luxury-fabric-kraig-biocraft-laboratories-targets-apparel-first-with-engineered-spider-silk Health & Wellness Today New York en PressRelease 2026-04-02T13:05:00+00:00 From Lab Fiber to Luxury Fabric: Kraig Biocraft Laboratories Targets Apparel First with Engineered Spider Silk https://ml.globenewswire.com/media/ZWEyZTUxNjctYmYxZS00MzM1LWI4ODYtZDFiMjc0ZjU5YTY5LTUwMDE1MTA3NC0yMDI2LTA0LTAyLWVu/tiny/24-7-Market-News-and-Kraig-Lab.png https://www.healthwellnesstodaynewyork.com/article/903343771-sienna-announces-first-quarter-2026-results-release-date-and-conference-call Health & Wellness Today New York en PressRelease 2026-04-02T13:00:00+00:00 Sienna Announces First Quarter 2026 Results Release Date and Conference Call https://ml.globenewswire.com/media/ac969f39-0111-4903-8faa-0cdee524eb4e/small/sienna-logo-rgb-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903343778-prenetics-announces-nba-champion-and-two-time-mvp-giannis-antetokounmpo-as-im8-global-partner-and-shareholder-in-multi-year-partnership Health & Wellness Today New York en PressRelease 2026-04-02T13:00:00+00:00 Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership https://ml.globenewswire.com/media/bc89f070-b05a-450e-8fbe-c22e860740da/medium/giannis-im8.jpg https://www.healthwellnesstodaynewyork.com/article/903341669-protecting-healthy-futures-unity-consortium-urges-families-to-prioritize-adolescent-health-during-immunization-action-week Health & Wellness Today New York en PressRelease 2026-04-02T12:55:00+00:00 Protecting Healthy Futures: Unity Consortium Urges Families to Prioritize Adolescent Health During Immunization Action Week https://ml.globenewswire.com/media/2b3eeef1-5425-448e-bb1f-18115321d7a8/small/unity-logo-horiz-png.png https://www.healthwellnesstodaynewyork.com/article/903341881-dr-joseph-mikhael-steps-into-new-role-as-medical-advisor-for-the-international-myeloma-foundation Health & Wellness Today New York en PressRelease 2026-04-02T12:45:00+00:00 Dr. Joseph Mikhael Steps into New Role as Medical Advisor for the International Myeloma Foundation https://ml.globenewswire.com/media/f70068f9-568b-4858-8283-3c96a2db91d6/small/imf-logo-png.png https://www.healthwellnesstodaynewyork.com/article/903343796-entera-bio-announces-pricing-of-10-0-million-direct-investment-by-bvf-partners-with-potential-for-up-to-24-5-million-in-total-proceeds Health & Wellness Today New York en PressRelease 2026-04-02T12:45:00+00:00 Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds https://ml.globenewswire.com/media/9b4ae2bf-733d-4180-b48c-d0fa3f26c81a/small/logo-png.png https://www.healthwellnesstodaynewyork.com/article/903344079-catalyst-medtech-announces-acquisition-of-x3d Health & Wellness Today New York en PressRelease 2026-04-02T12:39:45+00:00 Catalyst MedTech Announces Acquisition of X3D https://ml.globenewswire.com/media/NTczOTM3ZWYtMGI1YS00ZTAyLWE5NGEtN2ZkZmI1MTFmZjhjLTEzMTYxMTAtMjAyNi0wNC0wMi1lbg==/tiny/Catalyst-MedTech.png https://www.healthwellnesstodaynewyork.com/article/903344092-practicelink-reveals-evolved-brand-identity-focused-on-clarity-simplicity-and-trust-for-healthcare-providers-and-recruiters Health & Wellness Today New York en PressRelease 2026-04-02T12:34:44+00:00 PracticeLink Reveals Evolved Brand Identity Focused on Clarity, Simplicity and Trust for Healthcare Providers and Recruiters https://ml.globenewswire.com/media/4489702d-d167-45a5-8e6b-873bd89d1590/small/2026-practicelink-logo-vertical-clr-png.png https://www.healthwellnesstodaynewyork.com/article/903341101-biodexa-announces-partnership-with-syngene-to-manufacture-mtx240-gmp-clinical-trial-supplies Health & Wellness Today New York en PressRelease 2026-04-02T12:30:00+00:00 Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies https://ml-eu.globenewswire.com/media/8367259c-e117-4264-9988-26f7e36b032f/small/biodexa-logo-square-1-png.png https://www.healthwellnesstodaynewyork.com/article/903341980-intelligent-bio-solutions-completes-clinical-cut-off-study-advances-fda-510-k-clinical-program-targeting-multi-billion-dollar-u-s-drug-screening Health & Wellness Today New York en PressRelease 2026-04-02T12:30:00+00:00 Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market https://ml.globenewswire.com/media/d4eaef42-9420-48b7-8019-0285720d678c/small/ibs-primary-logo-blue-png.png https://www.healthwellnesstodaynewyork.com/article/903342712-ultragenyx-announces-u-s-fda-acceptance-of-bla-resubmission-for-ux111-aav-gene-therapy-to-treat-sanfilippo-syndrome-type-a-mps-iiia Health & Wellness Today New York en PressRelease 2026-04-02T12:30:00+00:00 Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA) https://ml.globenewswire.com/media/121a9bda-7a64-41f8-85e8-1693a2dfa977/small/ultragenyx-cmyk-png.png https://www.healthwellnesstodaynewyork.com/article/903342973-abeona-therapeutics-announces-new-qualified-treatment-center-for-zevaskyn-in-new-york Health & Wellness Today New York en PressRelease 2026-04-02T12:30:00+00:00 Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York https://ml.globenewswire.com/media/f11f9f14-9744-4666-aef3-9771488c41bd/small/thumb-1740-12-silhouette-vertical-full-color-png.png https://www.healthwellnesstodaynewyork.com/article/903343218-onconetix-highlights-realbotix-ai-humanoid-robot-delivery-update Health & Wellness Today New York en PressRelease 2026-04-02T12:30:00+00:00 Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update https://ml.globenewswire.com/media/4824d51d-2ecb-4f49-8b75-fe9b920e7b1c/small/onconetix-logo-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903343227-oncotelic-therapeutics-announces-strategic-partnership-with-techforce-robotics-to-commercialize-pdaoai-enhanced-gmp-robotics-platform Health & Wellness Today New York en PressRelease 2026-04-02T12:30:00+00:00 Oncotelic Therapeutics Announces Strategic Partnership with TechForce Robotics to Commercialize PDAOAI-Enhanced GMP Robotics Platform https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903343744-sienna-completes-acquisition-in-greater-toronto-area Health & Wellness Today New York en PressRelease 2026-04-02T12:30:00+00:00 Sienna Completes Acquisition in Greater Toronto Area https://ml.globenewswire.com/media/ac969f39-0111-4903-8faa-0cdee524eb4e/small/sienna-logo-rgb-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903341404-nanox-signs-distribution-agreement-with-integrity-medical-service-inc-to-deploy-nanox-arc-systems Health & Wellness Today New York en PressRelease 2026-04-02T12:11:00+00:00 Nanox Signs Distribution Agreement with Integrity Medical Service, Inc. to Deploy Nanox.ARC Systems https://ml-eu.globenewswire.com/media/7a1764f8-84e3-4b28-ae23-9add5d57c378/small/nanox-logo-4-png.png https://www.healthwellnesstodaynewyork.com/article/903342205-curanex-expands-its-drug-development-pipeline-to-include-cancer-cachexia-representing-a-multi-billion-dollar-market-opportunity-and-important-step-in Health & Wellness Today New York en PressRelease 2026-04-02T12:07:00+00:00 Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company https://ml.globenewswire.com/media/29bc3de5-6a82-4a17-a165-6a79eef16d74/small/logo-png.png https://www.healthwellnesstodaynewyork.com/article/903341085-mdic-appoints-philips-chief-medical-officer-carla-goulart-peron-as-new-board-member Health & Wellness Today New York en PressRelease 2026-04-02T12:00:00+00:00 MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member https://ml-eu.globenewswire.com/media/e5826782-01bc-45e7-b448-9ca1eae0125e/small/philips-logo-logotype-emblem-700x128-png.png https://www.healthwellnesstodaynewyork.com/article/903341734-picard-medical-syncardia-coo-to-deliver-keynote-at-venture-caf-phoenix-during-arizona-tech-week Health & Wellness Today New York en PressRelease 2026-04-02T12:00:00+00:00 Picard Medical / SynCardia COO to Deliver Keynote at Venture Café Phoenix During Arizona Tech Week https://ml.globenewswire.com/media/93c733bb-b54a-41af-856b-6d01c1f724a2/small/syncardia-x-picard-email-signature-2025-1-png.png https://www.healthwellnesstodaynewyork.com/article/903341755-tvardi-therapeutics-to-participate-in-the-raymond-james-biotech-innovation-symposium Health & Wellness Today New York en PressRelease 2026-04-02T12:00:00+00:00 Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium https://ml.globenewswire.com/media/65859e40-e7db-474e-b604-78033b160f6b/small/tvardi-therapeutics-logo-1200-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903341946-catheter-precision-engages-strategic-advisor Health & Wellness Today New York en PressRelease 2026-04-02T12:00:00+00:00 Catheter Precision Engages Strategic Advisor https://ml.globenewswire.com/media/cb9f10dc-be78-4c7c-a235-81bfdd77f03c/small/catheterlogo-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903341989-calidi-biotherapeutics-to-present-new-data-on-its-lead-asset-cld-401-at-the-aacr-annual-meeting-in-april-2026 Health & Wellness Today New York en PressRelease 2026-04-02T12:00:00+00:00 Calidi Biotherapeutics to Present New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026 https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903342225-emergent-biosolutions-participates-in-upcoming-international-preparedness-conferences Health & Wellness Today New York en PressRelease 2026-04-02T12:00:00+00:00 Emergent BioSolutions Participates in Upcoming International Preparedness Conferences https://ml.globenewswire.com/media/56a9097d-af91-4bcf-8c42-5905e1614ef1/small/emerge-png.png https://www.healthwellnesstodaynewyork.com/article/903342277-cocrystal-pharma-receives-fda-fast-track-designation-for-cdi-988-for-norovirus-infection-treatment-and-preventive Health & Wellness Today New York en PressRelease 2026-04-02T12:00:00+00:00 Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive https://ml.globenewswire.com/media/a5071a3a-c592-43ba-bfee-77c2867982ba/small/cocrystal-logo-final-highres-792x612-png.png https://www.healthwellnesstodaynewyork.com/article/903342676-milestone-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health & Wellness Today New York en PressRelease 2026-04-02T12:00:00+00:00 Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/49b2e16b-2deb-4c9e-9c20-6cc4fd6c15ab/small/milestone-pharmaceuticals-logo-png.png https://www.healthwellnesstodaynewyork.com/article/903343297-bionano-announces-publication-from-johns-hopkins-and-md-anderson-showing-that-ogm-can-outperform-traditional-methods-in-analysis-of-multiple-myeloma Health & Wellness Today New York en PressRelease 2026-04-02T12:00:00+00:00 Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma https://ml.globenewswire.com/media/5ba4072e-6e59-46e7-847c-6aaf7755bbbf/small/bionano-rgb-png.png https://www.healthwellnesstodaynewyork.com/article/903343298-revolution-medicines-begins-treating-patients-in-phase-3-rasolute-303-trial-evaluating-daraxonrasib-as-first-line-treatment-for-patients-with Health & Wellness Today New York en PressRelease 2026-04-02T12:00:00+00:00 Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer  https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://www.healthwellnesstodaynewyork.com/article/903343584-commure-introduces-dictation-ai-powered-clinical-voice-now-at-the-cursor Health & Wellness Today New York en PressRelease 2026-04-02T12:00:00+00:00 Commure Introduces Dictation: AI-Powered Clinical Voice, Now at the Cursor https://ml.globenewswire.com/media/1136e76f-ef70-46bf-997e-5f9b1b8b2ff6/small/commure-logo-full-horizontal-black-3-png.png https://www.healthwellnesstodaynewyork.com/article/903341778-plus-therapeutics-secures-highmark-coverage-for-cnside-csf-assay-expanding-reimbursement-to-75-million-covered-lives Health & Wellness Today New York en PressRelease 2026-04-02T11:30:00+00:00 Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png https://www.healthwellnesstodaynewyork.com/article/903341792-mink-therapeutics-to-present-new-data-at-asgct-2026-highlighting-context-dependent-activity-of-inkt-cell-therapy Health & Wellness Today New York en PressRelease 2026-04-02T11:30:00+00:00 MiNK Therapeutics to Present New Data at ASGCT 2026 Highlighting Context-Dependent Activity of iNKT Cell Therapy https://ml.globenewswire.com/media/6aa8e960-515a-40d6-9894-39ca47f5c84e/small/mink-logo-loyal-blue-and-light-blue-png.png https://www.healthwellnesstodaynewyork.com/article/903342388-context-therapeutics-announces-ctim-76-receives-fda-fast-track-designation-for-the-treatment-of-platinum-resistant-ovarian-cancer Health & Wellness Today New York en PressRelease 2026-04-02T11:30:00+00:00 Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer https://ml.globenewswire.com/media/67b45666-397e-4c48-af45-ffd653bbfddf/small/context-therapeutics-inc.jpg https://www.healthwellnesstodaynewyork.com/article/903342707-annovis-secures-u-s-patent-for-buntanetap-in-the-prevention-and-treatment-of-neurological-injuries-caused-by-brain-infections Health & Wellness Today New York en PressRelease 2026-04-02T11:30:00+00:00 Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections https://ml.globenewswire.com/media/7ee459df-d33f-4f42-b27c-3bd20487d50c/small/annovis-corp-image-png.png https://www.healthwellnesstodaynewyork.com/article/903342662-cylinder-health-launches-stool-scan-to-innovate-and-standardize-one-of-gi-care-s-most-subjective-signals Health & Wellness Today New York en PressRelease 2026-04-02T11:10:00+00:00 Cylinder Health launches Stool Scan to innovate and standardize one of GI care’s most subjective signals https://ml.globenewswire.com/media/cfb89636-f442-479b-87c5-e2c3f43b777c/small/main-cylinder-wordmark-rgb-black-png.png https://www.healthwellnesstodaynewyork.com/article/903343341-adagene-announces-pricing-of-us-70-0-million-public-offering-of-adss Health & Wellness Today New York en PressRelease 2026-04-02T11:10:00+00:00 Adagene Announces Pricing of US$70.0 Million Public Offering of ADSs https://ml.globenewswire.com/media/c377318b-edf7-42c0-8e7c-63a02bbe47b0/small/adagene-logo-gnw-png.png https://www.healthwellnesstodaynewyork.com/article/903342592-cartesian-therapeutics-announces-new-employment-inducement-grants Health & Wellness Today New York en PressRelease 2026-04-02T11:05:00+00:00 Cartesian Therapeutics Announces New Employment Inducement Grants https://ml.globenewswire.com/media/2bf78841-be30-4bb5-bfb5-0b5f383f3302/small/cartesian-logo-color-png.png https://www.healthwellnesstodaynewyork.com/article/903343176-adagene-announces-clinical-collaboration-with-incyte-to-evaluate-muzastotug-adg126-in-combination-with-incyte-s-tgf-r2xpd-1-bispecific-antibody Health & Wellness Today New York en PressRelease 2026-04-02T11:01:00+00:00 Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC) https://ml.globenewswire.com/media/c377318b-edf7-42c0-8e7c-63a02bbe47b0/small/adagene-logo-gnw-png.png https://www.healthwellnesstodaynewyork.com/article/903342811-updated-data-from-phase-1b-2-study-of-muzastotug-in-combination-with-keytruda-pembrolizumab-in-late-line-patients-with-microsatellite-stable Health & Wellness Today New York en PressRelease 2026-04-02T11:00:00+00:00 Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Late-line Patients with Microsatellite Stable Colorectal Cancer Demonstrate Improved Durability of Response https://ml.globenewswire.com/media/c377318b-edf7-42c0-8e7c-63a02bbe47b0/small/adagene-logo-gnw-png.png https://www.healthwellnesstodaynewyork.com/article/903342871-neutrolis-announces-positive-first-in-human-phase-1a-results-from-liberate-i-trial-of-ntr-1011-a-first-in-class-dnase1l3-fusion-protein Health & Wellness Today New York en PressRelease 2026-04-02T11:00:00+00:00 Neutrolis Announces Positive First-in-Human Phase 1a Results from LIBERATE-I Trial of NTR-1011, a First-in-Class DNASE1L3 Fusion Protein https://ml.globenewswire.com/media/44cdba09-fdb9-4ee1-b7bf-1dcfe5784800/small/20180228-opr-or-logos-biz-wd-neutrolis-logo-1-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903343172-skye-bioscience-treats-first-patient-in-nimacimab-higher-dose-expansion-study-evaluating-exposure-response-to-inform-phase-2b-dose-selection-for-glp-1 Health & Wellness Today New York en PressRelease 2026-04-02T11:00:00+00:00 Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development https://ml.globenewswire.com/media/905e06d8-af43-4f7a-b097-8c12ce1d3aa0/small/skye-darkblue-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903321591-pharvaris-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-business-update Health & Wellness Today New York en PressRelease 2026-04-02T10:50:00+00:00 Pharvaris Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png https://www.healthwellnesstodaynewyork.com/article/903321923-burning-rock-announces-founder-s-purchase-of-its-adss Health & Wellness Today New York en PressRelease 2026-04-02T10:25:59+00:00 Burning Rock Announces Founder’s Purchase of Its ADSs https://ml.globenewswire.com/media/904d8c1b-eae2-4b6f-83ed-3cb8d0ad31f6/small/logo-01-png.png https://www.healthwellnesstodaynewyork.com/article/903321555-arch-biopartners-closes-non-brokered-private-placement Health & Wellness Today New York en PressRelease 2026-04-02T09:45:00+00:00 Arch Biopartners Closes Non-Brokered Private Placement https://ml.globenewswire.com/media/8fae7e83-0899-4bbc-ba40-0250cdb9aea7/small/logo-png.png https://www.healthwellnesstodaynewyork.com/article/903321482-roivant-announces-expansion-of-brepocitinib-development-program-with-new-phase-2b-3-trial-in-lichen-planopilaris-lpp-and-phase-3-study-results-for Health & Wellness Today New York en PressRelease 2026-04-02T09:00:00+00:00 Roivant Announces Expansion of Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP) and Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED) https://ml.globenewswire.com/media/f1a5db68-ee4f-437f-b4e6-2b840ae6a536/small/roivantlogo-png.png https://www.healthwellnesstodaynewyork.com/article/903321557-priovant-expands-brepocitinib-development-program-with-new-phase-2b-3-trial-in-lichen-planopilaris-lpp Health & Wellness Today New York en PressRelease 2026-04-02T09:00:00+00:00 Priovant Expands Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP) https://ml.globenewswire.com/media/OTFhNWNlNjItZDZhZC00NWMwLTg1ZDEtMDE5MGI1ODhhYjZjLTEwMzAxODQtMjAyNi0wNC0wMi1lbg==/tiny/Roivant-Sciences-Inc-.png https://www.healthwellnesstodaynewyork.com/article/903321596-immunovant-announces-phase-3-study-results-for-batoclimab-in-thyroid-eye-disease-ted Health & Wellness Today New York en PressRelease 2026-04-02T09:00:00+00:00 Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED) https://ml.globenewswire.com/media/7062c765-82cc-4ba2-ba1f-4b1396b9b052/small/immulogo-jpg.jpg https://www.healthwellnesstodaynewyork.com/article/903303851-mygevity-announces-nationwide-launch-of-integrated-health-data-platform Health & Wellness Today New York en PressRelease 2026-04-02T08:31:46+00:00 MyGevity Announces Nationwide Launch of Integrated Health Data Platform https://ml.globenewswire.com/Resource/Download/57c484c8-5351-4c6a-9b57-34085204291c/image1.png https://www.healthwellnesstodaynewyork.com/article/903247534-celldex-announces-pricing-of-300-million-public-offering-of-common-stock Health & Wellness Today New York en PressRelease 2026-04-02T01:48:19+00:00 Celldex Announces Pricing of $300 Million Public Offering of Common Stock https://ml.globenewswire.com/media/7a6cc287-087f-4e97-878f-7c1ed1dc5949/small/celldex-logo-rgb-png.png https://www.healthwellnesstodaynewyork.com/article/903247472-metatrim-bhb-claims-evaluated-the-quick-burn-keto-bhb-formula-everyone-is-researching-meta-trim-ketones Health & Wellness Today New York en PressRelease 2026-04-02T01:34:30+00:00 MetaTrim BHB Claims Evaluated: The Quick Burn Keto BHB Formula Everyone is Researching, Meta Trim Ketones https://zingfast.com/wp-content/uploads/2026/04/MetaTrim-BHB.jpg https://www.healthwellnesstodaynewyork.com/article/903247452-good-oral-health-isn-t-complicated-alberta-s-dentists-want-you-to-know-what-works Health & Wellness Today New York en PressRelease 2026-04-02T01:10:54+00:00 Good oral health isn't complicated — Alberta's dentists want you to know what works https://ml.globenewswire.com/media/caec844b-ce06-4a8a-8b80-a9cc1fb1337e/small/ada-rgb-colour-highres-png.png https://www.healthwellnesstodaynewyork.com/article/903230162-telix-appoints-david-gill-as-non-executive-director Health & Wellness Today New York en PressRelease 2026-04-01T23:53:07+00:00 Telix Appoints David Gill as Non-Executive Director https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png